Skip to content

IH LIFE SCIENCES: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

IH LIFE SCIENCES

BE 0687.864.810
NACE 86.910, Medical imaging and medical laboratories
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€3,459
2024 · -€40,797+€44,256
Equity
€377,493
2024 · €374,034+€3,459
Cash
€35,215
2024 · €266,623-€231,408
Balance sheet total
€503,586
2024 · €376,955+€126,632

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€414,950

    up €414,950 (+1290.0%), from €32,168 to €447,118

    of which Land and buildings: +€420,805

  • Cash -€231,408

    down €231,408 (-86.8%), from €266,623 to €35,215

    mainly Investment in fixed assets (net) (-€441,413) and Short-term financial debts (-€200)

  • Receivables within one year -€55,446

    down €55,446 (-98.4%), from €56,326 to €879

    of which Other amounts receivable: -€55,571

Equity and liabilities
  • Other debts +€122,265

    new in 2025: €122,265

Income statement
  • Gross operating margin +€38,339

    up €38,339, from -€13,291 to €25,048

  • Taxes -€26,418

    down €26,418, from €22,216 to -€4,201

  • Depreciation +€20,608

    up €20,608 (+352.0%), from €5,855 to €26,463

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€40,797
Gross operating margin +€38,339
Depreciation -€20,608
Other operating charges +€23
Financial income -€140
Financial charges +€224
Taxes +€26,418
Result 2025 €3,459

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€210,204
Investment -€441,413
Financing -€200
Cash 2024 €266,623
Net result for the year +€3,459
Depreciation +€26,463
Receivables within one year +€55,446
Deferred charges and accrued income +€1,464
Smaller working-capital items +€1,107
Other debts +€122,265
Investment in fixed assets (net) -€441,413
Short-term financial debts -€200
Cash 2025 €35,215
Every line side by side 42 lines
Line Code 2024 2025 Change %
Total assets 20/58 €376,955 €503,586 +€126,632 +33.6%
Fixed assets 21/28 €32,168 €447,118 +€414,950 +1290.0%
Tangible fixed assets 22/27 €32,168 €447,118 +€414,950 +1290.0%
Land and buildings 22 - €420,805 +€420,805
Other tangible fixed assets 26 €32,168 €26,313 -€5,855 -18.2%
Current assets 29/58 €344,787 €56,469 -€288,318 -83.6%
Amounts receivable within one year 40/41 €56,326 €879 -€55,446 -98.4%
Trade receivables 40 €0 €125 +€125
Other amounts receivable 41 €56,326 €754 -€55,571 -98.7%
Current investments 50/53 €15,000 €15,000 = 0.0%
Cash at bank and in hand 54/58 €266,623 €35,215 -€231,408 -86.8%
Deferred charges and accrued income 490/1 €6,838 €5,374 -€1,464 -21.4%
Total equity and liabilities 10/49 €376,955 €503,586 +€126,632 +33.6%
Equity 10/15 €374,034 €377,493 +€3,459 +0.9%
Contributions 10/11 €12,400 €12,400 = 0.0%
Reserves 13 €361,634 €365,093 +€3,459 +1.0%
Tax-exempt reserves 132 €0 - =
Distributable reserves 133 €361,634 €365,093 +€3,459 +1.0%
Amounts payable 17/49 €2,921 €126,093 +€123,173 +4217.1%
Amounts payable within one year 42/48 €2,921 €126,032 +€123,112 +4215.0%
Financial debts 43 €200 €0 -€200 -100.0%
Credit institutions 430/8 €200 €0 -€200 -100.0%
Trade debts 44 €1,639 €1,956 +€317 +19.4%
Suppliers 440/4 €1,639 €1,956 +€317 +19.4%
Taxes, remuneration and social security 45 €1,082 €1,811 +€729 +67.4%
Taxes 450/3 €1,082 €1,811 +€729 +67.4%
Other amounts payable 47/48 - €122,265 +€122,265
Accrued charges and deferred income 492/3 - €61 +€61
Non-recurring operating income 76A - €28,082 +€28,082
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €5,855 €26,463 +€20,608 +352.0%
Other operating charges 640/8 €375 €352 -€23 -6.1%
Gross operating margin 9900 -€13,291 €25,048 +€38,339
Operating profit (loss) 9901 -€19,520 -€1,766 +€17,754 +91.0%
Financial income 75/76B €2,456 €2,316 -€140 -5.7%
Recurring financial income 75 €2,456 €2,316 -€140 -5.7%
Financial charges 65/66B €1,516 €1,292 -€224 -14.8%
Recurring financial charges 65 €1,516 €1,292 -€224 -14.8%
Profit (loss) for the period before taxes 9903 -€18,581 -€742 +€17,839 +96.0%
Income taxes 67/77 €22,216 -€4,201 -€26,418
Profit (loss) for the period 9904 -€40,797 €3,459 +€44,256
Transfer from tax-exempt reserves 789 €134,350 €0 -€134,350 -100.0%
Profit (loss) for the period to be appropriated 9905 €93,553 €3,459 -€90,094 -96.3%

Source: filed annual accounts (NBB), fiscal years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.